admission date:  [2134-4-19]              discharge date:   [2134-5-11]date of birth:  [2061-11-2]             sex:   mservice: medicineallergies:patient recorded as having no known allergies to drugsattending:[first name3 (lf) 12131]chief complaint:hypotensionmajor surgical or invasive procedure:endoscopysigmoidoscopyportacath removal[first name3 (lf) ] catheter placement[first name3 (lf) ]history of present illness:72m with pmh significant for metastatic rectal cancer was atradiology clinic receiving scheduled imaging when blood pressureat triage recorded 60/40. recheck was 70/40. his port wasaccessed and he was bolused with 300cc of ivf and transferred tothe ed. he denied syncope or lightheadedness but reported mildsob and fatigue. he reports having several days of diahrrea,which began last wednesday [4-14]. his last dose of irinotecan andpanitumab chemotherapy was monday [2134-3-29] (patient reports was[4-12] but not recorded in omr), and he reports always gettingdiahrrea with his chemotherapy. he reports haveing watery bowelmovements roughly every 45 minutes since wednesday. his bowelmovements are not bloody or melanaic. he has been takingimmodium and diphenoxylate-atropine without improvement. sundaynight, he reports acute worsening of his diahrrea, whichcontinued through monday. ems gave him another 500cc of ns priorto arrival to the ed..on arrival to the ed his vitals were 98.0 100/50 83 18 100%ra.cr was 1.3 from 1.1. hct was 27.3. mg was 0.8mg. he was guaiacnegative. ct torso was without pe or dissection, but did havemultiple stable pulmonary nodules, and a small right pleuraleffusion. he also had stable metastatic disease. ekg was sinusin the 70's. he was given 3l of ns and 4 grams of mg..review of systems:(+) per hpi.he is denying fevers, abdominal pain, chest pain, hematochezia,melena.past medical history:past oncologic history:adenocarcinoma of the rectum- [6-/2131]:  the patient presented with a change in bowel habitsand was noted to have an abnormal rectal exam by his primarycarephysician, [name10 (nameis) 39262] [name initial (nameis) ] gastrointestinal evaluation.- [2131-7-23] colonoscopy:  exophytic cancer of the rectum [9-9]cmabove the anal margin.  polyp noted at the anorectal junction.biopsy:  invasive, moderately differentiated adenocarcinomaarising in association with adenoma. polyp:  adenoma withhigh-grade dysplasia.- [2131-7-25] rectal ultrasound:  t3 posterior midline tumor withluminal narrowing of the rectum.- [2131-8-2] ct scan of the torso:  irregular, polypoid lesionseen within the rectum, with multiple subcentimeter presacralandpericolic lymph nodes identified.  two pulmonary nodules seen inthe left lower lobe, the largest measuring 2.9 x 2.2 cm.multiplelow-attenuation lesions seen within the liver, thelargest of which may represent cyst, smaller lesions are notfully characterized.  low-attenuation lesions seen within theleft kidney, possibly a cyst, although too small tocharacterize.per report, a ct pet performed elsewhere demonstrated uptake inthe left base of the lung.- [2131-8-14] to [2131-9-25]:  neoadjuvant chemoradiation withcontinuous 5-fu at 225 mg/m2/day and radiation therapy five daysweekly.- [2131-12-10]:  proctosigmoidectomy with stapled coloanalanastomosis and diverting loop ileostomy.  pathology revealedadenocarcinoma of the rectum, low-grade, with invasion into theperirectal adipose tissue and metastasis to 7 of 13 regionallymph nodes (t3n2).  the resection margins were uninvolved.- [2132-1-28] pet scan: interval progression of disease with anincrease in the size of the previously identifiedlung metastasis. there is a new fdg-avid focus in segment 4a ofthe liver which most likely represents metastasis.- [2132-2-13]: ileostomy takedown with simultaneous flexiblebronchoscopy and vats with left lower lobe resection.  pathologyfrom the ileostomy stoma demonstrated no evidence of malignancy.the left lower lobe wedge resection demonstrated anadenocarcinoma, 4.1 cm, consistent with metastasis of rectalorigin.  the pleural and apparent stapled margins were free ofmalignancy.- [2132-2-14]: evaluation by the hepatobiliary surgery consultteam due to the finding on his recent pet scan of a likely livermetastasis. it was felt that the lesion was amenable to surgicalresection, and it was planned that the patient would undergo twocycles of chemotherapy prior to proceeding with hepaticresection.- [2132-4-9]: folfox chemotherapy initiated. the patient completedtwo cycles of therapy on [2132-6-3].- [2132-7-11]: hepatic resection of a 1.7cm segment 4a metastaticlesion by dr. [last name (stitle) ].- [2132-10-22]: cycle 1 day 1 5fu/lv for further adjuvantchemotherapy. oxaliplatin eliminated due to neuropathy. thepatient completed therapy in [1-5].- [2132-11-26]: hospital admission for svc syndrome secondary to acatheter-associated thrombus causing occlusion of the svc andbilateral brachiocephalic veins. the patient underwent tpainfusion followed by venous angioplasty with balloon dilationwith resolution of symptoms. he was discharged on enoxaparin.- [2133-8-3]: initiation of ininotecan for recurrent disease.- [2134-2-8]: due to laboratory and radiographic evidence ofdiseaseprogression, cetuximab was added to ininotecan; due to anallergic reaction, cetuximab was changed to panitumumab on[2134-2-16]..other past medical history:1.  hypertension.2.  hyperlipidemia.3.  ascvd, status post mi in [2111].4.  status post appendectomy.5.  diabetessocial history:the patient lives alone and is divorced.  he hasthree sons in their 40s.  he is a construction inspector.  hedenies alcohol use and drug use.  he smoked one pack ofcigarettes daily for 30 years before quitting.family history:the patient's paternal uncle had an abdominalcancer, details unknown.  his father died of an mi.  his motherdied of [name (ni) 2481] disease.  he has two brothers who are well.physical exam:admission:gen: awake, alert, nadvs: 97.6 110/46 88 19 100% 2lheent: eomi, mmmcv: irregularly irregular, no m/g/rpulm: crackles at rllabd: well healed scars on abdomen, soft, nt, ndlimbs: no edemaskin: erythema and excoriation over left antecubital fossa.discharge:gen: nad, aaox3heent: mmm, oropharynx clear.cv: rrr, no m/r/gpulm: ctab, decreased breath sounds at bases. tunneled [name (ni) 2286]catheter noted on right chest, c/d/iabd: soft, distended, nt, +bs.extr: 2+ bilateral lower extremity edema, 2+ bilateral upperextremity edema, left > right 2+ dp pulses bilaterally.skin: blanching macules noted scattered across forearms andupper back.pertinent results:admission labs:[2134-4-19] 11:35am blood wbc-2.8 rbc-3.30 hgb-9.3 hct-27.3mcv-83 mch-28.3 mchc-34.2 rdw-20.0 plt ct-283[2134-4-19] 11:35am blood pt-14.0 ptt-35.5 inr(pt)-1.2[2134-4-19] 11:35am blood glucose-199 urean-23 creat-1.3 na-139k-4.0 cl-106 hco3-22 angap-15[2134-4-19] 11:35am blood calcium-8.3 phos-2.4 mg-0.8.discharge labs:micro:[4-20]:clostridium difficile toxin a & b test (final [2134-4-21]):      feces negative for c.difficile toxin a & b by eia.           (reference range-negative).   fecal culture (final [2134-4-22]):    no salmonella or shigellafound.   campylobacter culture (final [2134-4-22]):    no campylobacterfound..[2134-5-4] 12:58 am stool     consistency: soft      source:stool.                            final report [2134-5-4]   clostridium difficile toxin a & b test (final [2134-5-4]):      feces negative for c.difficile toxin a & b by eia.           (reference range-negative).[2134-4-27] 11:47 am catheter tip-iv                            final report [2134-4-29]   gram stain (final [2134-4-27]):      test cancelled, patient credited.      inappropriate specimen for gram stain.   wound culture (final [2134-4-29]):      staph aureus coag +.    >15 colonies.         staphylococcus species may develop resistance duringprolonged         therapy with quinolones.   therefore, isolates that areinitially         susceptible may become resistant within three to fourdays after         initiation of therapy.  testing of repeat isolates maybe         warranted.                              sensitivities: mic expressed inmcg/ml_________________________________________________________                             staph aureus coag +                             |clindamycin-----------<=0.25 serythromycin----------<=0.25 sgentamicin------------ <=0.5 slevofloxacin----------<=0.12 soxacillin-------------   0.5 strimethoprim/sulfa---- <=0.5 s[2134-4-24] 2:47 pm blood culture      source: line-picc.                            final report [2134-4-29]   blood culture, routine (final [2134-4-29]):      staph aureus coag +.         sensitivities performed on culture # 294-1510a[2134-4-23].         consultations with id are recommended for all bloodcultures         positive for staphylococcus aureus and [female first name (un) 564] species.      staph aureus coag +.    second morphology.         consultations with id are recommended for all bloodcultures         positive for staphylococcus aureus and [female first name (un) 564] species.         staphylococcus species may develop resistance duringprolonged         therapy with quinolones.   therefore, isolates that areinitially         susceptible may become resistant within three to fourdays after         initiation of therapy.  testing of repeat isolates maybe         warranted.                              sensitivities: mic expressed inmcg/ml_________________________________________________________                             staph aureus coag +                             |clindamycin-----------<=0.25 serythromycin----------<=0.25 sgentamicin------------ <=0.5 slevofloxacin----------  0.25 soxacillin-------------     1 strimethoprim/sulfa---- <=0.5 s   anaerobic bottle gram stain (final [2134-4-26]):      gram positive cocci in pairs and clusters.   aerobic bottle gram stain (final [2134-4-26]):      gram positive cocci in clusters.[4-19] ecg:sinus rhythm with ventricular premature beat. rightbundle-branch block. sincethe previous tracing of [2132-11-27] inferior lead q waves are lessprominent..[4-19] ct torso:1. no evidence of pulmonary embolism or dissection. multiplesmall pulmonarynodules are overall stable in size. stable small right-sidedpleuraleffusion.2. stable extent of metastatic disease in the abdomen.3. two small ventral wall hernias containing loops of smallbowel, but noevidence of obstruction with oral contrast seen to the colon.4. cholelithiasis..[2134-4-26] rue ultrasound.indication: 72-year-old man with swollen left arm and left-sidedport-a-cath.comparison: none.technique: grayscale and doppler evaluation of left upperextremity.findings: grayscale and doppler evaluation of the left internaljugular,subclavian, axillary, basilic, and brachial veins demonstratenormal flow,compressibility, and response to augmentation whereverapplicable. nointraluminal thrombus was identified.impression: no evidence of dvt in the left upper extremity.[2134-4-27] renal ultrasound:indication: 72 year old man with acute kidney failure andsepsis.comparison: cta chest performed [2134-4-19].renal ultrasound: the left kidney measures 10.9 cm. the rightkidneymeasures 10.7 cm. there is no hydronephrosis, stone or mass ineither kidney.the bladder is unremarkable.impression: unremarkable renal ultrasound without evidence ofhydronephrosis.brief hospital course:mr. [known lastname 1683] is a 72 yo m with h/o metastatic rectal ca and svcsyndrome, now resolved on lovenox tx, who was admitted to omedon [4-19] with intractable diarrhea thought [3-2] chemo andtransferred to the [hospital unit name 153] on [4-24] with brbpr and hematemesis. giwas consulted and an egd was performed on [4-24] which showeddiffuse erythema/ulceration, in esophagus, stomach, duodenum.this was thought due to irinotecan induced gi toxicity.  theyrecommended ppi and carafate slurry.  they were concerned thatpatient's whole gi tract was diffusely inflamed as was seen onegd and that the anastamotic site from his colectomy might be ableeding source; a flex sigmoidoscopy was done on as well andshowed as well diffuse ulceration and inflammation. hcts and q6hhemodynamics remained stable throughout his hospital course.the patient was started on steroid enemas and mesalaminesuppositories to decrease inflammation.  the steroid enemas werediscontinued, but the mesalamine suppositories were continuedthrough to discharge.  in total, he received 3 units prbcs and 2units of ffp. stool cultures revealed no evidence of infection..on [4-24], the patient was found to have that 2/2 bottles of hisblood cultures drawn from his portacath were growing gpcs,speciation showed mssa. he was treated for this with ivvancomycin, leaving the portacath and picc in place. dailysurveillance blood cultures were performed and he was noted toclear his bacteremia on [4-26].  infectious diseases was consultedand the patient was switched to nafcillin with confirmation ofmssa.  the port-a-cath was removed which was the source ofinfection.the patient however despite aggressive crystalloid and colloid(albumin, a further 2 units of blood) resuscitation thendeveloped sepsis related acute tubular necrosis.  the patientbecame anuric and nephrology was consulted.  hemodialysis wasinitiated which the patient tolerated well, and a permanenttunneled catheter line was placed on [2134-5-7].  the patient wasstarted on phosphate binders, nephrocaps and erythropoeitindosed at hemodialysis.  the carafate was discontinued due torisk of aluminum toxicity.  the nafcillin was also changed tocefazolin dosed 2mg at each [date range 2286] session for ease ofadministration and avoiding extra volume loading.  should thepatient miss [initials (namepattern4) ] [last name (namepattern4) 2286] session, extra doses of cefazolin shouldbe administered as needed.  the patient was planned for a 28 daycourse of cefazolin to be finished on [2134-5-22]..other parts of his hospitalization are outlined by problembelow:.#hypotension/tachycardia: in setting of extensive diahrrea. cttorso is without pe or dissection. his bp initally recoveredwith 500cc ns bolus.  once he had an episode of brbpr, he becametacycardic to the 140s, with bp 90s/60s.  he was bolused ns andgiven prbc with improved hr to the 110s, and bp to 120s/80s..#svc syndrome: occurred in [2132]. s/p tpa infusion followed byvenous angioplasty with balloon dilation with resolution ofsymptoms.  he was initially treated with lovenox (doserecalculated this admission, should be lower than his admissiondose), but this was held secondary to gi bleed.  this was notrestarted at discharge given the patient's renal failure..#diarrhea - the patient continued to have diarrhea that wascontrolled with titration of his anti-diarrheal medications.infectious sources were ruled out and the cause was likelyirinotecan-induced gi toxicity and radiation proctitis.#generalized anasarca - the patient was noted to have anextremely low albumin on admission, likely related to poornutrition due to his gi pathology.  albumins ranged between 2.7and 1.9.  during volume resuscitation the patient became grosslyedematous, and albumin was administered to little effect.  hisleft upper extremity was noted to be more edematous than therest of his body, and a lue ultrasound was acquired.  thisdemonstrated no evidence of clot.  the patient slowly becameless edematous when [year (4 digits) 2286] was initiated and ultrafiltrationwas started.mr. [known lastname 1683]' code status was confirmed as full code  this hospitaladmission.medications on admission:diphenoxylate-atropine - 2.5 mg-0.025 mg tablet - [1-30] tablet(s)by mouth q6hr as needed for diarrheaenoxaparin [lovenox] - 150 mg/ml syringe - inject 150 mg once adaylisinopril - (prescribed by other provider) - 10 mg tablet - 1tablet(s) by mouth dailymetoprolol succinate [toprol xl] - (prescribed by otherprovider) - 100 mg tablet sustained release 24 hr - 1 tablet(s)by mouth dailymetronidazole [metrogel] - 1 % gel - apply to rash twice a dayprochlorperazine maleate - 10 mg tablet - 1 tablet(s) by mouthq6hr as needed for nauseasimvastatin - (prescribed by other provider) - 20 mg tablet - 1tablet(s) by mouth dailyloperamide [imodium a-d] - 2 mg tablet - 2 tablet(s) by mouthq4he as needed for diarrheapyridoxine - (otc) - 50 mg tablet - 2 tablet(s) by mouth once adaydischarge medications:1. diphenoxylate-atropine 2.5-0.025 mg tablet sig: 1-2 tabletspo q6h (every 6 hours) as needed for diarrhea.2. compazine 10 mg tablet sig: one (1) tablet po every six (6)hours as needed for nausea.3. simvastatin 20 mg tablet sig: one (1) tablet po once a day.4. loperamide 2 mg capsule sig: one (1) capsule po every four(4) hours as needed for diarrhea.5. pyridoxine 50 mg tablet sig: two (2) tablet po daily (daily).6. metoprolol tartrate 25 mg tablet sig: one (1) tablet po tid(3 times a day).7. ipratropium bromide 0.02 % solution sig: one (1) nebinhalation q6h (every 6 hours) as needed for shortness of breathor wheezing.8. simethicone 80 mg tablet, chewable sig: one (1) tablet,chewable po qid (4 times a day) as needed for bloating, gas.9. heparin flush (10 units/ml) 2 ml iv prn line flushpicc, heparin dependent: flush with 10ml normal saline followedby heparin as above daily and prn per lumen.10. ondansetron 4 mg iv q8h:prn nausea11. prochlorperazine 10 mg iv q6h:prn nausea12. cefazolin 2 g iv hd protocolhd protocol, to be given during hemodialysis13. diphenoxylate-atropine 2.5-0.025 mg tablet sig: one (1)tablet po q6h (every 6 hours) as needed for diarrhea.14. calcium acetate 667 mg capsule sig: one (1) capsule po tidw/meals (3 times a day with meals).15. b complex-vitamin c-folic acid 1 mg capsule sig: one (1) cappo daily (daily).16. heparin (porcine) 1,000 unit/ml solution sig: 4000-[numeric identifier 2249]unit injection prn (as needed) as needed for line flush: dwellprn line flush[numeric identifier ] catheter (tunneled 2-lumen): [numeric identifier ] nurse only:withdraw 4 ml prior to flushing with 10 ml ns followed byheparin as above according to volume per lumen..17. insulin lispro 100 unit/ml solution sig: sliding scale unitssubcutaneous asdir (as directed): 2 units for 101-1504 units for 151-2006 units for 201-2508 units for 251-30010 units for 301-35012 units for 351-400.18. mesalamine 1,000 mg suppository sig: one (1) suppositoryrectal daily (daily).19. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one(1) tablet, delayed release (e.c.) po q24h (every 24 hours).20. albuterol sulfate 2.5 mg /3 ml (0.083 %) solution fornebulization sig: one (1) nebulizer inhalation q6h (every 6hours) as needed for dyspnea.21. epogen 10,000 unit/ml solution sig: hemodialysis  protocolinjection with each [numeric identifier 2286] session.22. heparin (porcine) 5,000 unit/ml solution sig: one (1) mlinjection tid (3 times a day).discharge disposition:extended carefacility:[hospital6 979] - [location (un) 246]discharge diagnosis:rectal cancerdiarrheasepsisacute renal failuredischarge condition:mental status: clear and coherentlevel of consciousness: alert and interactivedischarge instructions:you were admitted to the hospital with diarrhea. we believe thediarrhea was a side effect of the chemotherapy you had received;it was treated with 3 anti-diarrheal medications. you also havea low blood pressure on admission, this was likely due todehydration in the setting of diarrhea, and it improved withrehydration with iv fluids. your diarrhea then became bloody,and you also had an episode of vomit with blood in it. as aresult, you were transferred to the icu.  you had an upperendoscopy and a sigmoidoscopy, which showed ulceration in youresophagus, stomach and colon.  this was thought to be due to thechemotherapy and radiation that you have been receiving for yourcolon cancer..while admitted, you also had a severe bacterial infection thatgot into your blood.  this severely damaged your kidneys,requiring you to be started on hemodialysis.  you had apermanent [location (un) 2286] catheter placed and you will need to continuegetting [location (un) 2286] 3 times a week.you were started on several new medications when you wereadmitted.nephrocaps 1 capsule dailyphos-lo 667mg three times a daymesalamine 1000mg suppositories once a daycefazolin 2g given with hemodialysispantoprazole 40mg dailyerythropoetin given with hemodialysisyour metoprolol was changed from 100mg once a day to 25mg threetimes a dayyour lisinopril and enoxaparin have been discontinued.followup instructions:you need to follow up with your outpatient oncologists, drs.[last name (stitle) ] and [name5 (ptitle) ] [name5 (ptitle) ] discuss any further treatment for yourectal cancer.dr. [first name8 (namepattern2) 636] [last name (namepattern1) ] and dr. [last name (stitle) ] in colorectal cancer clinic on[5-31] at 10 am. you can reach the office by calling [telephone/fax (1) 22249].provider: [first name4 (namepattern1) 2747] [last name (namepattern1) 5780], rn phone:[telephone/fax (1) 22]date/time:[2134-5-24] 10:00completed by:[2134-5-12]